Detalhe da pesquisa
1.
TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV entry into hepatocytes via an IL-6-dependent mechanism.
Gut
; 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38697771